The study also met all secondary endpoints with a reduction in severity of VMS at weeks 4 and 12, a reduction in frequency of VMS at week 1 as well as improvements in sleep disturbances and menopause related quality of life
The order, part of an international framework agreement is to be executed between February to April, 2025
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
Exploring new opportunities within the fast-growing market of microfluidics
Till 30th November 2024, more than 2690 PACS have been given initial approval and 687 Kendras have been opened in PACS
Recommendation based on LAURA Phase III trial results which showed Tagrisso extended median progression-free survival to more than three years
Opinion granted based on positive overall survival results from the IND.227/KEYNOTE-483 trial
The FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit
Subscribe To Our Newsletter & Stay Updated
